CIK 0001133416 · Non-accelerated filer<br>Smaller reporting company
GALECTIN THERAPEUTICS INC
Sign in to watch- Ticker
- GALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 043562325
- Phone
- 678-620-3186
- Business address
- 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
- Former names
- PRO PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-10 | CALLICUTT JACK W Chief Financial Officer | Option exercise · Stock option (right to buy) 10b5-1 | −1,675 | 37,891 | ||
| 2025-11-10 | CALLICUTT JACK W Chief Financial Officer | Option exercise · Stock option (right to buy) 10b5-1 | −1,736 | 51,073 | ||
| 2025-11-05 | LEWIS JOEL President and CEO | Option exercise · Stock option (right to buy) 10b5-1 | −1,867 | 22,363 | ||
| 2025-11-05 | LEWIS JOEL President and CEO | Option exercise 10b5-1 | +200 | $2.39 | $478 | 832,792 |
| 2025-11-05 | LEWIS JOEL President and CEO | Sale 10b5-1 | −200 | $6.00 | $1K | 832,592 |
| 2025-11-05 | LEWIS JOEL President and CEO | Option exercise · Stock option (right to buy) 10b5-1 | −200 | 24,230 | ||
| 2025-11-05 | CALLICUTT JACK W Chief Financial Officer | Option exercise 10b5-1 | +200 | $1.98 | $396 | 7,814 |
| 2025-11-05 | CALLICUTT JACK W Chief Financial Officer | Sale 10b5-1 | −200 | $6.00 | $1K | 7,614 |
| 2025-11-05 | CALLICUTT JACK W Chief Financial Officer | Option exercise 10b5-1 | +200 | $1.11 | $222 | 7,814 |
| 2025-11-05 | CALLICUTT JACK W Chief Financial Officer | Sale 10b5-1 | −200 | $6.00 | $1K | 7,614 |
| 2025-11-05 | CALLICUTT JACK W Chief Financial Officer | Option exercise 10b5-1 | +200 | $1.72 | $344 | 7,814 |
| 2025-11-05 | CALLICUTT JACK W Chief Financial Officer | Sale 10b5-1 | −200 | $6.00 | $1K | 7,614 |
| 2025-11-05 | CALLICUTT JACK W Chief Financial Officer | Option exercise · Stock option (right to buy) 10b5-1 | −200 | 39,586 | ||
| 2025-11-05 | CALLICUTT JACK W Chief Financial Officer | Option exercise · Stock option (right to buy) 10b5-1 | −200 | 39,566 | ||
| 2025-11-05 | CALLICUTT JACK W Chief Financial Officer | Option exercise · Stock option (right to buy) 10b5-1 | −200 | 52,809 | ||
| 2025-11-04 | LEWIS JOEL President and CEO | Option exercise 10b5-1 | +14,420 | $2.39 | $34K | 847,012 |
| 2025-11-04 | LEWIS JOEL President and CEO | Sale 10b5-1 | −14,420 | $6.07 | $88K | 832,592 |
| 2025-11-04 | LEWIS JOEL President and CEO | Option exercise · Stock option (right to buy) 10b5-1 | −14,420 | 24,530 | ||
| 2025-11-04 | CALLICUTT JACK W Chief Financial Officer | Option exercise 10b5-1 | +8,914 | $1.98 | $18K | 16,528 |
| 2025-11-04 | CALLICUTT JACK W Chief Financial Officer | Sale 10b5-1 | −8,914 | $6.07 | $54K | 7,614 |
Page 9 of 15 · 291 trades